Liver cancer patient saved

A patient with advanced hepatocellular carcinoma (liver cancer) who participated in the Phase II trials of namodenoson from Israel’s Can-Fite (see here previously) had an extremely good response. His liver function returned to normal, and he is looking forward to a good quality of life.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *